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Introduction {#sec1}
============

Epilepsy is one of the most prevalent neurological disorders characterized by recurrent seizures resulting from excessive excitation or inadequate inhibition of neurons ([@bib32], [@bib4]). Neuromodulation techniques have gained widespread attention owing to their therapeutic utility for epilepsy. They used physical means to modulate neuronal activity, thereby decreasing the frequency or duration of seizures ([@bib24]).

Ultrasound neuromodulation has gained global attention in recent years owing to its bimodal modulatory effects with exquisite spatial specificity and depth penetration. The evidence from animal and human studies with healthy subjects illustrates that ultrasound can penetrate the skull to the specific brain regions causing behavioral change and improving sensory discrimination abilities ([@bib25], [@bib13], [@bib6], [@bib7]). Recent studies have demonstrated that ultrasound stimulation can inhibit the epileptic seizures in a rodent model of epilepsy ([@bib10], [@bib15]). Min et al. showed that low-intensity, pulsed ultrasound sonication suppressed the number of epileptic signal bursts using the acute epilepsy model in the rat ([@bib19]). Also, Hakimova et al. indicated that ultrasound stimulation effectively inhibited acute seizure activity, including status epilepticus, and subsequent recurrent seizures in the chronic period in a kainate-induced mouse model of mesial temporal lobe epilepsy ([@bib10]). Recently, Li et al. reported that low-intensity ultrasound could effectively modulate nonlinear dynamics in acute epileptic mice ([@bib15]). These findings suggested a potential role for ultrasound in the treatment of epilepsy, but it has not yet been tested whether ultrasound stimulation can inhibit seizures in nonhuman primates with epilepsy.

We aimed to determine whether ultrasound stimulation was capable of functionally modulating brain activity in non-human primates with epilepsy. The effectiveness of ultrasound neuromodulation was identified by a penicillin-induced epilepsy model in non-human primates ([@bib17]). The results indicated that the number of seizures was significantly reduced, whereas the inter-seizure interval was increased after ultrasound stimulation. The present study suggested that ultrasound may offer a non-invasive method for the treatment of epilepsy.

Results {#sec2}
=======

Examination of the Effect of Ultrasound Parameters on Epileptic Seizures {#sec2.1}
------------------------------------------------------------------------

The sonication parameters were selected based on real-time monitoring of behavior and electroencephalograph (EEG). Ultrasound waves with different frequencies and durations were delivered to the prefrontal motor cortex ([Figure 1](#fig1){ref-type="fig"}). We found that ultrasound stimulation at a frequency of 800 kHz, a pulse repetition frequency (PRF) of 500 Hz, a duty cycle of 36%, and an acoustic pressure of 1.74 MPa reduced the number of seizures compared with ultrasound stimulation at a frequency of 750 kHz ([Figure 2](#fig2){ref-type="fig"}A). In addition, the number of seizures was reduced when ultrasound was delivered at a frequency of 800 kHz, a PRF of 500 Hz, and an acoustic pressure of 1.74 MPa for 15 min ([Figure 2](#fig2){ref-type="fig"}B). Therefore, a frequency of 800 kHz and a duration of 15 min were used as the ultrasound parameters in subsequent experiments.Figure 1Schematic of the Ultrasound Neuromodulation System(A) The experimental process. (B) Ultrasound transducer was placed on the scalp and fixed to the mechanical arm. The coupling cone was filled with PVA phantom. (C) Acoustic field distributions in longitudinal plane without and with mouse monkey skull measured by the OptiSon Ultrasound Beam Analyzer (Onda, USA). Scale bar, 10 mm. (D) Acoustic pressure distribution in axial plane without and with mouse monkey skull measured by a calibrated hydrophone. Scale bar, 2mm.Figure 2Ultrasound Parameters Selection and Video-EEG within 7 h after Ultrasound StimulationUltrasound transducers with a frequency of 750 kHz and 800 kHz were used to stimulate for 30 min and 60 min. By observing the total number of epileptic seizures, we found that the two transducers had the same effect on epileptic EEG. B. An 800 kHz ultrasound transducer was used to stimulate epileptic monkeys with difference time, and under the action of different ultrasonic stimulation time, the number of seizures was as follow: sham (133.3 ± 16.36), 5 min (119), 15 min (63), 30 min (77) and 60 min (108). We found that 15 min ultrasound stimulation had an obvious inhibition effect. C. The total number of epileptic seizures was significantly reduced after ultrasound stimulation (sham: 129.1 ± 13.42, ultrasound: 75.75 ± 6.527, n = 8, independent-sample t-test, p \< 0.01). D. The duration of epileptic seizures was decreased after ultrasound stimulation (sham: 112.1 ± 15.33, ultrasound: 71.38 ± 11.9, n = 8, independent-sample t-test, p = 0.0544). E. The inter-seizure interval was longer with ultrasound stimulation than sham stimulation (sham: 307.9 ± 15.33, ultrasound: 348.6 ± 11.9, n = 8, independent-sample t-test, p = 0.0544). F. The frequency of epileptic seizures per hour after 15 min of ultrasound stimulation. The number of seizures gradually decreased in both groups as time progressed. 1^st^ hour (sham: 35.25 ± 4.636, ultrasound: 25 ± 3.423, n = 8, independent-sample t-test, p = 0.1265, 2^nd^ hour (sham: 33.625 ± 5.305, ultrasound: 16.625 ± 1.802, n = 8, independent-sample t-test, p = 0.0085), 3^rd^ hour (sham: 16.750 ± 3.098, ultrasound: 11.250 ± 1.623, n = 8, independent-sample t-test, p = 0.0889), 4^th^ hour (sham: 13.625 ± 1.812, ultrasound: 7.000 ± 1.604, n = 8, independent-sample t-test, p = 0.0318), 5^th^ hour (sham: 11.125 ± 2.539, ultrasound: 6.500 ± 2.104, n = 8, independent-sample t-test, p = 0.2506), 6^th^ hour (sham: 10.750 ± 2.975, ultrasound: 4.875 ± 1.922, n = 8, independent-sample t-test, p = 0.1633), 7^th^ hour (sham: 8.000 ± 2.619, ultrasound: 3.125 ± 1.274, n = 8, independent-sample t-test, p = 0.1218). G. The total number of seizures and the EEG power density with time in two groups. Data are represented as mean ± sem.

Ultrasound Neuromodulation Inhibits Behavioral Seizures {#sec2.2}
-------------------------------------------------------

After penicillin injection, all monkeys were monitored for behavioral seizures by continuous video-EEG recording. The total seizure counts for 7 h (sham: 129.1 ± 13.42, ultrasound: 75.75 ± 6.527, t test, p = 0.003) were significantly reduced after 15 min of ultrasound treatment ([Figure 2](#fig2){ref-type="fig"}C). Seizure monkeys were randomly selected for ultrasound stimulation; the result revealed that the monkeys in the ultrasound stimulation group had a shorter seizure duration (sham: 112.1 ± 15.33 min, ultrasound: 71.38 ± 11.9 min, t test, p = 0.0544), as shown in [Figure 2](#fig2){ref-type="fig"}D. [Figure 2](#fig2){ref-type="fig"}E indicated that the mean interval between seizures was 307.9 ± 15.33 min in the sham group and 348.6 ± 11.9 min in the stimulation group (p = 0.0544). In addition, we observed that the mean number of seizures per hour in the ultrasound stimulation group was lower than that in the sham stimulation group ([Figures 2](#fig2){ref-type="fig"}F, 2G, and [S1](#mmc1){ref-type="supplementary-material"}). These results showed a trend in the suppression of acute seizures in non-human primates by ultrasound stimulation.

The Safety of Ultrasound Neuromodulation {#sec2.3}
----------------------------------------

To evaluate the safety of ultrasound neuromodulation, we visualized the temperature change on the surface of the skull during ultrasound stimulation using a thermal infrared imager (R300, NEC Avio, Tokyo, Japan). After 15 min of ultrasound stimulation, the temperature rise was approximately 0.3°C ([Figure S2](#mmc1){ref-type="supplementary-material"}). In addition, T2-weighted MR imaging showed that there was no tissue damage or bleeding after ultrasound stimulation ([Figures 3](#fig3){ref-type="fig"}A and 3B, [Videos S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}).Figure 3MRI images of monkeys stimulated by ultrasound.MRI images of monkeys stimulated by ultrasound. T2-weighted MR imaging was performed after ultrasound stimulation. The red arrows indicated where the stimulation was applied to. No pathological damage was found in each monkey after ultrasound stimulation. Scale bar, 1 cm.

Discussion {#sec3}
==========

This study demonstrated that noninvasive ultrasound stimulation could inhibit acute seizures in monkeys. Video-EEG recordings from the epileptic foci tend to show that ultrasound neuromodulation reduced the frequency and duration of seizures and increased the inter-seizure interval in a penicillin-induced epilepsy nonhuman primate model.

Epilepsy is a prevalent neurological disorder resulting in disruptive seizures and is often associated with pharmaco-resistance. Neuromodulation techniques have recently been employed to modulate aberrant neuronal activity and decrease the frequency or duration of seizures. These techniques employ physical means to modulate neuronal activity, thereby decreasing the frequency or duration of seizures ([@bib16], [@bib12], [@bib22], [@bib2], [@bib1]). Compared with deep brain stimulation and optogenetics, ultrasound can noninvasively penetrate the skull to reversibly modulate neuronal activity and does not require the implantation of an electrode or optical source ([@bib29], [@bib5], [@bib30]). Ultrasound neuromodulation has a higher spatial resolution and offers deeper tissue penetration than non-invasive neuromodulation methods, such as transcranial magnetic stimulation and transcranial direct current stimulation ([@bib31], [@bib6], [@bib7]). In this study, we found that ultrasound could noninvasively stimulate the prefrontal motor cortex and inhibit behavioral seizures in monkeys. Overall, low-intensity ultrasound neuromodulation is a promising noninvasive brain stimulation tool that appears to have neuromodulatory effects associated with behavioral changes.

In this study, we found that the inhibitory effect could last for 7 h after 15 min of ultrasound stimulation ([Figure 2](#fig2){ref-type="fig"}). In addition, Davide Folloni et al. indicated that 40-s of ultrasound stimulation could cause brain activity of macaque monkeys for more than 1 h ([@bib6]). These suggest that ultrasound may offer possible non-invasive treatment of epilepsy.

The mechanism by which ultrasound inhibits seizures was not examined in this study. Most authors champion nonthermal mechanical mechanisms of ultrasound neuromodulation. Recently, we reported that ultrasound could open the *Escherichia coli* mechanosensitive channel of large conductance (MscL) to control neuronal activities ([@bib26]). Moreover, Huang et al. indicated that the therapeutic mechanism of ultrasound neuromodulation could possibly be attributed to promoted brain-derived neurotrophic factor (BDNF) expression ([@bib11]). In addition, we found that ultrasound conferred neuroprotection in Parkinson\'s disease mice ([@bib27], [@bib28]). An important study on the mechanism of ultrasound to suppress epileptic seizures is confirmed by our recent research ([@bib17]). We used patch-clamp to record brain slices of patients with epilepsy and found that ultrasound stimulation can inhibit neuronal excitability in brain slices from epileptic patients, and the inhibition efficiency is more than 65%. In addition, we observed increased expression of c-Fos protein in GABAergic neurons, suggesting that ultrasound stimulation may enhance GABAergic neuron activity and increase the inhibitory postsynaptic inputs. But, owing to the different ultrasound parameters used in two studies, the potential mechanism of ultrasound stimulation for treatment of epilepsy still needs to be studied.

Magnetic resonance imaging showed that ultrasound neuromodulation did not cause any tissue damage, which may suggest that ultrasound is a safe neuromodulation tool. Previous studies have shown that ultrasound was able to mitigate focal cerebral ischemia in rats ([@bib9], [@bib14]), reduce essential tremors in rats ([@bib23]), and modulate brain function in humans ([@bib20]). Our recent studies have indicated that ultrasound stimulation can improve motor function in Parkinson\'s disease model mice ([@bib27], [@bib28]). In a study of 54 cases of ultrasound regulating the central nervous system, only two had ultrasound-related injuries ([@bib3]). Another study on magnetic resonance acoustic radiation force imaging also pointed out that localized brain regions did not cause tissue damage after ultrasound stimulation ([@bib8]). Therefore, ultrasound may be a safe, noninvasive therapeutic method for the modulation of neurological disorders, including epilepsy and Parkinson\'s disease.

Limitations of Study {#sec3.1}
--------------------

Our research also has several limitations that should be addressed in the future. First, there were only two animals used in our study; to further verify the role and mechanism of ultrasound neuromodulation technology in non-human primate epilepsy models, we will need to increase the number of animals in the future. Second, from the current experimental results, the ultrasound duration time plays a significant role in the effect of ultrasound to inhibit seizures. We should focus on more point-in-time of ultrasound in the future. Different combinations of ultrasonic parameters were also crucial. Third, the acute epilepsy model was used in our experiments. This model is helpful for us to study the role of ultrasound neuromodulation in epilepsy. However, chronic human temporal epilepsy is more common in human diseases. The other models were studied in the next study. In addition, to reduce the attenuation of the skull, the array ultrasound transducer with low frequency will be developed to deliver ultrasound energy to the targeted region.

Video S1. The MRI Videos of Monkey A, Related to Figure 3

Video S2. The MRI Videos of Monkey B, Related to Figure 3

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The authors confirm that the data supporting the findings of this study are available within the article and its supplemental materials.
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